ITP
ITP
Advertisement
Patrick DalyITP | October 31, 2023
Efgartigimod, a first-in-class IgG1 Fc fragment, promisingly separated from placebo in patients with chronic ITP.
Read More
The Fellow on CallThe Fellow on Call | September 5, 2023
The group continues their analysis of emergencies by exploring immune thrombocytopenic purpura.
Patrick DalyITP | August 28, 2023
The relationship between T-cell large granular lymphocytes (T-LGL) and immune thrombocytopenia (ITP) is unclear, ...
Patrick DalyITP | August 28, 2023
A recent publication from Fathima Haseefa and colleagues suggested that immune thrombocytopenia (ITP) was independently ...
Patrick DalyITP | August 28, 2023
In a recent study, researchers sought to evaluate clinical presentations, course, management, and outcomes of idiopathic ...
Patrick DalyITP | August 28, 2023
Researchers, led by Judit Demeter, evaluated the safety and efficacy profiles of a novel 10% human intravenous ...
Patrick DalyITP | August 28, 2023
In a recent meta-analysis, investigators evaluated the safety and efficacy profiles of romiplostim, a thrombopoietin ...
Patrick DalyITP | August 28, 2023
Researchers performed a study to compare the clinical efficacy and side effects of low-dose (LD) oral prednisone against ...
Patrick DalyITP | August 28, 2023
In a study published in Hematology, researchers evaluated CD72 expression levels and any associated functions in B ...
Patrick DalyITP | August 28, 2023
Monocytes and macrophages play an established role in the pathophysiology of hematopoietic malignancies, including ...
Patrick DalyITP | August 28, 2023
IFNG antisense RNA 1 (IFNG-AS1) and growth arrest-specific 5 (GAS5) are long noncoding RNAs (lncRNAs) associated with ...
Patrick DalyITP | August 28, 2023
Investigators sought to characterize first-line and subsequent therapies for immune thrombocytopenia (ITP) used in ...
Patrick DalyITP | August 28, 2023
In a study published in Contrast Media & Molecular Imaging, researchers explored the absolute value of peripheral ...
Patrick DalyITP | August 28, 2023
Researchers evaluated the clinical efficacy of adding recombinant human thrombopoietin (rhTPO) to glucocorticoids in the ...
Patrick DalyITP | August 28, 2023
Noting the relevance of autoimmune disorders in the pathogenesis of immune thrombocytopenia (ITP), researchers evaluated ...
Patrick DalyITP | August 28, 2023
In a study published in Experimental Hematology & Oncology, researchers used metagenomic sequencing to examine ...
Patrick DalyITP | August 28, 2023
Researchers, led by Soo Min Ahn, examined patients with primary immune thrombocytopenia (ITP) who later developed ...
Patrick DalyITP | August 28, 2023
Researchers led by Jinhua Wei developed a nomogram model for individualized predictions of risk for upper respiratory ...
Patrick DalyITP | August 28, 2023
In a study in International Immunopharmacology, researchers reported that immune thrombocytopenia (ITP) appeared to ...
Patrick DalyITP | August 28, 2023
In a study in the Journal of Pediatric Hematology/Oncology, researchers reevaluated the prognostic value of absolute ...
Advertisement
Advertisement
Advertisement
Latest News

July 12, 2024